Skip to content
OpenCapital
Get started

Edwards Lifesciences EW Cash & Equivalents

Cash & Equivalents at other companies

Travel + Leisure logo
Travel + LeisureTNL
$456M+24.3%
Warrior Met Coal logo
Warrior Met CoalHCC
$210.55M-54.5%
Main Street Capital logo
Main Street CapitalMAIN
$20.79M-81.0%
Cabot Corporation logo
Cabot CorporationCBT
$252M+18.3%
Unifirst logo
UnifirstUNF
$151.79M-21.0%
HES
Hess MidstreamHESM
$4.6M-24.6%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%—

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's cash & equivalents?
Edwards Lifesciences (EW) reported cash & equivalents of $2.45B in Q1 2026.
How has Edwards Lifesciences's cash & equivalents changed year-over-year?
Edwards Lifesciences's cash & equivalents decreased by 22.3% year-over-year, from $3.15B to $2.45B.
What is the long-term trend for Edwards Lifesciences's cash & equivalents?
Over 5 years (2020 to 2025), Edwards Lifesciences's cash & equivalents has grown at a 19.6% compound annual growth rate (CAGR), from $1.2B to $2.94B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.